Table 3 Relationship between prednisone use and asthma exacerbations, defined as two or more annual ED or inpatient visits for respiratory issues, among African Americans and Caucasians
Patients with < 2 annual ED/inpatient visits for respiratory issues N (%) | Patients with ≥ 2 annual ED/inpatient visits for respiratory issues N (%) | Chi square, P value | |
|---|---|---|---|
African Americans (N = 6379) | |||
Prednisone | |||
No | 4536 (89.41%) | 1078 (82.54%) | X2 = 46.4781, |
Yes | 537 (10.59%) | 228 (17.46%) | P < 0.0001 |
Caucasians (N = 13,176) | |||
Prednisone | |||
No | 10,071 (89.99%) | 1675 (84.38%) | X2 = 54.8241, |
Yes | 1120 (10.01%) | 310 (15.62%) | P < 0.0001 |